Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...
-Company continues to advance PGN-EDO51 in CONNECT1-EDO51, with the 10 mg/kg cohort now fully enrolled- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...
– FREEDOM-DM1 data from 5 and 10 mg/kg cohorts in patients with DM1 expected in the first quarter of 2025 – – Study designs of CONNECT program optimized based on encouraging results from early...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.46 | -23.5897435897 | 1.95 | 2.03 | 1.45 | 186117 | 1.91549257 | CS |
| 4 | -2.36 | -61.2987012987 | 3.85 | 3.94 | 1.45 | 197777 | 2.41133257 | CS |
| 12 | -5.66 | -79.1608391608 | 7.15 | 7.15 | 1.45 | 221834 | 4.01077979 | CS |
| 26 | -16.04 | -91.5002852253 | 17.53 | 17.77 | 1.45 | 172716 | 6.39360761 | CS |
| 52 | -5.81 | -79.5890410959 | 7.3 | 19.298 | 1.45 | 141605 | 9.4503844 | CS |
| 156 | -14.11 | -90.4487179487 | 15.6 | 20 | 1.45 | 114207 | 10.15140433 | CS |
| 260 | -14.11 | -90.4487179487 | 15.6 | 20 | 1.45 | 114207 | 10.15140433 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
